Clinical Trial Finder | Pancreatic Cancer Action Network

Back to Trial Search

Phase Ib/II Study of HCW9218, a Bifunctional TGF-ß Antagonist/IL-15 Protein Complex, for Advanced Pancreatic Cancer

The purpose of this phase I/II study is to evaluate the safety and tolerability of HCW9218 in patients with advanced pancreatic adenocarcinoma.

NCT#: NCT05304936
Study ID: HCWPAN102
Trial Phase: Phase I/II

Trial Sponsor: HCW Biologics
Therapies Used in This Trial: HCW9218

Request a Healthcare Provider account to access Trial Eligibility and Site Information.

An authorized Healthcare Provider account is required to access Trial Eligibility and Site Information. Already have an account? Sign In

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account.
In order to view this information, you need to be signed in as a Health Care Provider.
In order to see the trial eligibility criteria, you need to be signed in as a Health Care Provider.
This information is restricted to validated Health Care Providers.

-------------------------------------------------------------------------------------------

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account by clicking on the Request button.
------------------------------------------------------------------------------------------------------
In order to view this information, you need to be signed in as a Health Care Provider. You are currently not authorized.

Back to Trial Search